Terms: = Head and neck cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Treatment
761 results:
1. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
Chen Y; Xiao X; Hu G; Liu R; Xue J
J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
[TBL] [Abstract] [Full Text] [Related]
2. Activation of the MEK/erk Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
3. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
Sang Y; Min R; Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
[TBL] [Abstract] [Full Text] [Related]
4. Systemically Administered D-allose Inhibits the Tumor Energy Pathway and Exerts Synergistic Effects With Radiation.
Samukawa Y; Ouchi Y; Miyashita T; Rahman A; Tsukamoto I; Yoshihara A; Hoshikawa H
Anticancer Res; 2024 May; 44(5):1895-1903. PubMed ID: 38677730
[TBL] [Abstract] [Full Text] [Related]
5. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
6. Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells.
Wu CC; Chen MS; Lee TY; Huang TS; Cho DY; Chen JY
Viral Immunol; 2024 Mar; 37(2):115-123. PubMed ID: 38498796
[TBL] [Abstract] [Full Text] [Related]
7. Curcumin Analog L48H37 Induces Apoptosis in Human Oral cancer Cells by Activating Caspase Cascades and Downregulating the Inhibitor of Apoptosis Proteins through JNK/p38 Signaling.
Su CW; Kao SH; Chen YT; Hsieh YH; Yang WE; Tsai MY; Lin CW; Yang SF
Am J Chin Med; 2024; 52(2):565-581. PubMed ID: 38480502
[TBL] [Abstract] [Full Text] [Related]
8. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological and molecular characteristics of esophageal carcinoma with ductal differentiation: analysis of 17 cases].
Jiang WJ; Ao S; Cui YY; Lu L; Wang CN
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):276-281. PubMed ID: 38433056
[No Abstract] [Full Text] [Related]
10. Cysteine protease inhibitor 1 promotes metastasis by mediating an oxidative phosphorylation/MEK/erk axis in esophageal squamous carcinoma cancer.
Zhang L; Chen X; Wang J; Chen M; Chen J; Zhuang W; Xia Y; Huang Z; Zheng Y; Huang Y
Sci Rep; 2024 Feb; 14(1):4985. PubMed ID: 38424293
[TBL] [Abstract] [Full Text] [Related]
11. A case of esophageal squamous cell carcinoma accompanied by pancreatic and bile duct metastases: Successful treatment starts with an accurate diagnosis.
Ito Y; Ikura Y; Sawai H; Osuga T
J Cancer Res Ther; 2023 Oct; 19(7):2060-2063. PubMed ID: 38376319
[TBL] [Abstract] [Full Text] [Related]
12. p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
Yassin-Kassab A; Chatterjee S; Khan N; Wang N; Sandulache VC; Huang EH; Burns TF; Duvvuri U
BMC Cancer; 2024 Feb; 24(1):233. PubMed ID: 38373988
[TBL] [Abstract] [Full Text] [Related]
13. The assessment of the mechanism of action of lauric acid in the context of oral cancer through integrative approach combining network pharmacology and molecular docking technology.
Buva K; Kumbhar GM; Deshmukh A; Ladke VS
J Complement Integr Med; 2024 Mar; 21(1):101-112. PubMed ID: 38353231
[TBL] [Abstract] [Full Text] [Related]
14. AKR1C3 silencing inhibits autophagy-dependent glycolysis in thyroid cancer cells by inactivating erk signaling.
Gao Y; Tao W; Wang S; Duan R; Zhang Z
Drug Dev Res; 2024 Feb; 85(1):e22142. PubMed ID: 38349266
[TBL] [Abstract] [Full Text] [Related]
15. THBS1 promotes angiogenesis and accelerates ESCC malignant progression by the HIF-1/VEGF signaling pathway.
Zhou X; Xia Q; Chen M; Zhang X; Huang M; Zheng X; Wang S; Wu B; Du Z
Cell Biol Int; 2024 Mar; 48(3):311-324. PubMed ID: 38233982
[TBL] [Abstract] [Full Text] [Related]
16. Oral cancer cell to endothelial cell communication via exosomal miR-21/RMND5A pathway.
Sun YQ; Wang B; Zheng LW; Zhao JH; Ren JG
BMC Oral Health; 2024 Jan; 24(1):82. PubMed ID: 38229133
[TBL] [Abstract] [Full Text] [Related]
17. CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway.
Chen X; Shen H; Liu H; Tan L; Zhang N
Funct Integr Genomics; 2024 Jan; 24(1):10. PubMed ID: 38221563
[TBL] [Abstract] [Full Text] [Related]
18. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P
J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821
[TBL] [Abstract] [Full Text] [Related]
19. 2-Bromopalmitate inhibits malignant behaviors of HPSCC cells by hindering the membrane location of Ras protein.
Wang C; Cui ZY; Chang HY; Wu CZ; Yu ZY; Wang XT; Liu YQ; Li CL; Du XG; Li JF
Exp Biol Med (Maywood); 2023 Dec; 248(23):2393-2407. PubMed ID: 38159074
[TBL] [Abstract] [Full Text] [Related]
20. Proteolytic cleavage of amyloid precursor protein by ADAM10 promotes proliferation and migration via activating MAPKs pathway in tongue squamous cell carcinoma in vitro.
Hong Y; Wei Z; Wang Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):167-173. PubMed ID: 38158671
[TBL] [Abstract] [Full Text] [Related]
[Next]
